-

KARL STORZ unifies its US organizations under a central management team, Sonal Matai named US President

Enhanced organizational structure will drive innovation and improve engagement with and delivery of excellence to KARL STORZ customers, accelerating growth

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a leading family-owned medical technology company, today announced it will centralize management of its United States organizations, including its research and development, manufacturing, and commercial operations, to bring more innovative products to market worldwide with greater speed. Sonal Matai, who has led the US commercial business for two years, has been named President of KARL STORZ in the United States and will lead the effort to bring this ambitious transformation to life.

“The US is the world’s largest medical device market and also the largest market for KARL STORZ,” said Sonal Matai, US President of KARL STORZ. “Our 2,700 employees in the United States can now work together more closely to create an enhanced customer experience in this critical geography through innovative products and superior service.”

“Our new organizational structure will bring benefits to all our stakeholders. Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the US,” Matai added.

Matai was previously Managing Director, KARL STORZ Endoscopy-America, Inc. In that role, he spearheaded a period of significant innovation and market share expansion. His prior leadership experiences at large MedTech companies and start-ups, as well as his global outlook and dedication to innovation and customer satisfaction, have honed his ability to drive progress and steer market leadership.

About KARL STORZ

KARL STORZ United States is a leader in endoscopic technology and imaging solutions across virtually all surgical specialties. It is a subsidiary of KARL STORZ SE & Co. KG, an international medical technology company that is family-owned and based in Tuttlingen, Germany. KARL STORZ stands for visionary design, precision craftsmanship, and clinical effectiveness and has a portfolio that includes more than 15,000 products for human and veterinary medicine.

Contacts

MEDIA CONTACT:
Susan Mancia
Director, Integrated Marketing Communications
KARL STORZ United States
Phone: 562-841-1515
Email: susan.mancia@karlstorz.com

KARL STORZ United States


Release Summary
Three separate KARL STORZ subsidiaries are merging to form a single unified organization, consolidating R&D, manufacturing, and commercial operations.
Release Versions

Contacts

MEDIA CONTACT:
Susan Mancia
Director, Integrated Marketing Communications
KARL STORZ United States
Phone: 562-841-1515
Email: susan.mancia@karlstorz.com

Social Media Profiles
More News From KARL STORZ United States

KARL STORZ Expands Its Robotics Ecosystem Through Strategic Partnerships in the US

TUTTLINGEN, Germany--(BUSINESS WIRE)--Through new strategic partnerships across the robotics ecosystem in the United States, the family-owned MedTech company KARL STORZ is bringing together advanced 3D visualization, robotic technologies, digital capabilities, and operating room integration. The collaborations with Moon Surgical and Sovato support a more open and connected approach to surgical innovation, designed to expand access, improve workflow efficiency, and enable future models of surgic...

KARL STORZ Announces FDA Clearance for Rubina Lens for Open Surgery

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the Rubina™ Lens exoscope for open surgery, broadening the company’s near-infrared (NIR) imaging ecosystem across open and minimally invasive procedures in the United States. The digital, camera‑based Rubina™ Lens exoscope displays a real‑time, magnified 4K image of the surgical field on a monitor. With the ability to switch into NIR imaging u...

KARL STORZ Receives FDA Clearance for FIVE S 6.5 Bronchoscope

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the FIVE S 6.5 sterile single-use bronchoscope. The device offers a valuable new option for critical care physicians, intensivists, RTs, and ICU-based proceduralists seeking airway control solutions for high-risk patients—especially those managing heavy secretions or in urgent situations requiring fast airway clearance. “The FIVE S 6.5 single-...
Back to Newsroom